WAKIX® (pitolisant) Net Revenue of $172.8 Million for Second Quarter 2024; ~29% Growth Year-over-Year Next Generation Pitolisant High-Dose (HD) Program…
MIAMI, FL, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…
Leading women's health app sets new benchmark in rapidly expanding femtech industry LONDON, July 30, 2024 /PRNewswire/ -- Flo Health, the…
Dr. Abby C. Collier will take over from Leah Lariviere as Executive Director, effective August 1, 2024Vancouver, British Columbia--(Newsfile Corp.…
MIAMI, FL, July 29, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…
ORLANDO, FL / ACCESSWIRE / July 28, 2024 / Reality television sensation Scheana Shay received international accolades Saturday, July 27,…
As Canada's maternal health suffers from ongoing deficiencies, the foundation urges immediate prevention and intervention with a multifaceted approachOTTAWA, July…
MORRISTOWN, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to pushing the boundaries…
The Tafenoquine for Babesiosis clinical trial will be conducted at three sites: Yale University, Rhode Island Hospital and Tufts Medical…
First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18,…